FDA Delays Lilly’s Symbyax.

Sarasota Personal Injury Lawyer
Zyprexa Manufacturer May Face More Legal Woes

Editor: Joe Saunders
Firm: Saunders & Walker, P.A.
July 02, 2007
By Joe Saunders

Eli Lilly, the manufacturer of the drug Zyprexa, may face more legal troubles after the FDA told the company it would delay the approval of its new drug Symbyax for hard-to-treat depression because the agency wanted more information about the risk of diabetes in the medicine’s prescribing label. Symbyax combines Lilly’s antipsychotic pill Zyprexa and the antidepressant Prozac. Zyprexa has already been shown to cause diabetes and pancreatitis. The company has come under heavy criticism for failing to disclose dangerous and often fatal side effects such as
fever, stiff muscles, confusion, sweating, fast or irregular heartbeats, spasmodic muscular movements, sudden headaches, problems with vision, speech or balance, hallucinations, and increased thirst and frequent urination.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: